PARP inhibitors for BRCA1/2-mutated and sporadic ovarian cancer: current practice and future directions
PARP INHIBITORS
Synthetic inhibitors - PARP inhibitors
Combination therapy with PARP inhibitors
PYRIDAZINONE DERIVATIVES AS PARP INHIBITORS